Growth Metrics

Edwards Lifesciences (EW) Current Assets (2016 - 2026)

Edwards Lifesciences has reported Current Assets over the past 17 years, most recently at $6.7 billion for Q4 2025.

  • For Q4 2025, Current Assets rose 7.22% year-over-year to $6.7 billion; the TTM value through Dec 2025 reached $6.7 billion, up 7.22%, while the annual FY2025 figure was $6.7 billion, 7.22% up from the prior year.
  • Current Assets for Q4 2025 was $6.7 billion at Edwards Lifesciences, up from $6.4 billion in the prior quarter.
  • Over five years, Current Assets peaked at $6.7 billion in Q4 2025 and troughed at $3.1 billion in Q1 2021.
  • A 5-year average of $4.4 billion and a median of $3.8 billion in 2023 define the central range for Current Assets.
  • Biggest five-year swings in Current Assets: soared 65.4% in 2024 and later dropped 5.48% in 2025.
  • Year by year, Current Assets stood at $3.2 billion in 2021, then fell by 2.67% to $3.1 billion in 2022, then soared by 30.36% to $4.0 billion in 2023, then soared by 55.74% to $6.3 billion in 2024, then increased by 7.22% to $6.7 billion in 2025.
  • Business Quant data shows Current Assets for EW at $6.7 billion in Q4 2025, $6.4 billion in Q3 2025, and $6.6 billion in Q2 2025.